CAR-NK
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors (NCT05410717) | Second Affiliated Hospital of Guangzhou Medical University | 2022-06-01 |
Track CAR-NK automatically
Every clearance here is in the API, with alerts when new ones post.